Post-fibrillization nitration of alpha-synuclein abolishes its seeding activity and pathology formation in primary neurons and in vivo

Output Details

Increasing evidence points to post-translational modifications (PTMs) as key regulators of alpha-synuclein (α-Syn) function in health and disease. However, whether these PTMs occur before or after α-Syn pathology formation and their role in regulating α-Syn toxicity remain unclear. In this study, we demonstrate that post-fibrillization nitration of α-Syn fibrils induced their fragmentation, modified their surface and dynamic properties but not their structure, and nearly abolished their seeding activity in primary neurons and in vivo. Furthermore, we show that the dynamic and surface properties of the fibrils, rather than simply their length, are important determinants of α-Syn fibril seeding activity. Altogether, our work demonstrates that post-aggregation modifications of α-Syn may provide novel approaches to target a central process that contributes to pathology formation and disease progression. Finally, our results suggest that the pattern of PTMs on pathological aggregates, rather than simply their presence, could be a key determinant of their toxicity and neurodegeneration. This calls for reconsidering current approaches relying solely on quantifying and correlating the level of pathology to assess the efficacy of novel therapies, as not all α-Syn aggregates in the brain are pathogenic.
Tags
  • Alpha-synuclein
  • Fibril
  • In Vivo

Meet the Authors

  • User avatar fallback logo

    Sonia Donzelli

  • Sinéad O’Sullivan, PhD

    Key Personnel: Team Schapira

    German Center for Neurodegenerative Diseases

  • User avatar fallback logo

    Anne-Laure Mahul-Mellier

  • Ayse Ulusoy, PhD

    Key Personnel: Team Schapira

    German Center for Neurodegenerative Diseases

  • User avatar fallback logo

    Giuliana Fusco

  • User avatar fallback logo

    Senthil T. Kumar

  • User avatar fallback logo

    Anass Chiki

  • User avatar fallback logo

    Johannes Burtscher

  • User avatar fallback logo

    Manel L.D.Boussouf

  • User avatar fallback logo

    Iman Rostami

  • User avatar fallback logo

    Alfonso De Simono

  • Donato Di Monte, MD

    Co-PI (Core Leadership): Team Schapira

    German Center for Neurodegenerative Diseases

  • User avatar fallback logo

    Hilal. A. Lashuel